Skip to content

Multi-omics Analysis of COPD

Multi-omics Characterization of Acute Exacerbation of COPD: Integrated Precision Typing of Airway Microbiota, Inflammatory Biomarkers, and Gut Microbiota

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129695
Enrollment
Unknown
Registered
2026-08-07
Start date
2026-08-07
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Observation group:None

Sponsors

The Second Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 40 years old; 2. Diagnosed as COPD according to GOLD criteria (FEV1/FVC < 70%); 3. Priority will be given to patients with at least one history of acute exacerbation within the past year (excluding this one). If it is difficult to obtain recurrent cases, patients with the first case (0 in the past year) will be included; 4. This hospitalization was due to AECOPD and met the discharge criteria; 5. Agree to provide sputum, blood, and fecal samples; 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with pulmonary tuberculosis, active pneumonia (chest imaging (X-ray or CT) showing new pulmonary consolidation or infiltrative shadows, accompanied by clinical manifestations of acute lower respiratory tract infection (such as fever, purulent sputum) and laboratory inflammatory evidence (significant increase in CRP and PCT), and requiring targeted anti-infective treatment) and other acute severe infections; 2. Combined with malignant tumors, immunodeficiency diseases, cardiovascular and cerebrovascular diseases, and other major illnesses; 3. Systematic use of immunosuppressants; 4. Unable to complete follow-up; 5. Pregnant or lactating women; 6. Patients who refuse informed consent; 7. The researcher believes that it is not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Clinical recovery outcomes of patients 4 weeks after discharge;

Countries

China

Contacts

Public ContactTao Feng

The Second Hospital of Jiaxing

piaopiaogou@163.com+86 573 8208 0930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026